NCT04619433 2025-09-23A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.Jiangsu HengRui Medicine Co., Ltd.Phase 3 Terminated48 enrolled